Remote Follow-up with a Mobile Application Is Equal to Traditional Outpatient Follow-up After Bariatric Surgery: the BELLA Pilot Trial.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
06 2023
Historique:
received: 01 02 2023
accepted: 05 04 2023
revised: 04 04 2023
medline: 5 6 2023
pubmed: 21 4 2023
entrez: 20 04 2023
Statut: ppublish

Résumé

Medical follow-up after bariatric surgery is recommended. However, the compliance was poor. This study aimed to evaluate the feasibility of a smartphone-based fully remote follow-up (FU) program for patients after bariatric surgery. In the interventional group, patients were followed up using a smartphone application (app), through which questionnaires were sent regularly. Participants in the control group underwent standard FU at the outpatient clinic every three months. After 12 months, all the participants were evaluated at an outpatient clinic. Between August 2020 and March 2021, 44 and 43 patients in the interventional and control groups, respectively, were included in the analysis after three patients were lost to FU, and three withdrew their informed consent because they wished for more personal contact with medical caregivers. After 12 months, total weight loss (TWL), %TWL, and percentage of excess weight loss (%EWL) did not differ between groups. There were no significant differences in the complication rates, including surgical complications, malnutrition, and micronutrition deficiency. The parameters of bioelectrical impedance analysis and quality of life did not differ between the groups. Vitamins and minerals in serum were similar in both groups except for calcium, which was significantly higher in the interventional group (2.52 mmol/L vs. 2.35 mmol/L, p = 0.038). Fully remote FU with a smartphone application is at least as effective as traditional in-person FU in an outpatient clinic after bariatric surgery. Through remote FU, patients can save time and medical professionals may have more resources for patients with more severe problems.

Identifiants

pubmed: 37081252
doi: 10.1007/s11695-023-06587-2
pii: 10.1007/s11695-023-06587-2
pmc: PMC10119000
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1702-1709

Informations de copyright

© 2023. The Author(s).

Références

JMIR Mhealth Uhealth. 2022 Mar 14;10(3):e33940
pubmed: 35285809
Obstet Gynecol. 2021 Jun 1;137(6):1032-1040
pubmed: 33957663
Obes Surg. 2011 Jun;21(6):763-7
pubmed: 21197603
JMIR Mhealth Uhealth. 2022 Feb 15;10(2):e28886
pubmed: 35166684
J Med Internet Res. 2020 Dec 1;22(12):e24087
pubmed: 33147166
Obes Surg. 2022 Mar;32(3):904-911
pubmed: 35020125
Nutr J. 2011 Apr 21;10:35
pubmed: 21510854
Ann Intern Med. 2022 Feb;175(2):198-209
pubmed: 34843383
Obes Surg. 2021 Jun;31(6):2701-2708
pubmed: 33796974
Obesity (Silver Spring). 2014 Jan;22(1):5-13
pubmed: 24307184
Obes Surg. 2014 Apr;24(4):647-51
pubmed: 24464545
Obes Surg. 2009 Jun;19(6):732-7
pubmed: 19277799
Obes Surg. 2022 Nov;32(11):3641-3649
pubmed: 36074201
Obes Surg. 2012 Dec;22(12):1843-7
pubmed: 22923311
Surgery. 2006 Oct;140(4):524-9; discussion 529-31
pubmed: 17011899
JMIR Mhealth Uhealth. 2021 Nov 11;9(11):e32093
pubmed: 34748515
Obes Surg. 2021 Aug;31(8):3606-3614
pubmed: 33963975
Ann Surg. 2019 Nov;270(5):859-867
pubmed: 31592894
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720980612
pubmed: 33300414
Metabolism. 2016 Apr;65(4):574-85
pubmed: 26805016
Digit Health. 2022 Nov 30;8:20552076221129072
pubmed: 36478987
Ann Surg. 2015 Jul;262(1):86-92
pubmed: 25361223
Nat Rev Endocrinol. 2012 Sep;8(9):544-56
pubmed: 22525731
Nat Rev Nephrol. 2020 Dec;16(12):709-720
pubmed: 32778788
Surg Obes Relat Dis. 2016 Feb;12(2):350-6
pubmed: 26806726
Obes Surg. 2014 Jan;24(1):42-55
pubmed: 24081459
Obes Surg. 2020 Nov;30(11):4293-4299
pubmed: 32583298
Nutrients. 2021 Oct 20;13(11):
pubmed: 34835945
Matern Child Health J. 2021 Jul;25(7):1057-1068
pubmed: 33929653
Br J Surg. 2017 Sep;104(10):1362-1371
pubmed: 28657109
Obes Surg. 2017 Oct;27(10):2724-2732
pubmed: 28801703
Eur J Nutr. 2022 Feb;61(1):55-67
pubmed: 34302218
Surg Obes Relat Dis. 2013 Nov-Dec;9(6):956-62
pubmed: 23295164
Obes Surg. 2017 Nov;27(11):2905-2911
pubmed: 28470489
Obes Surg. 2020 Aug;30(8):2957-2962
pubmed: 32335866
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Surg Obes Relat Dis. 2012 Sep-Oct;8(5):533-41
pubmed: 22920965
Obes Surg. 2022 Mar;32(3):625-633
pubmed: 34846686
Obes Surg. 2016 Apr;26(4):900-3
pubmed: 26757922
Obes Surg. 2005 Apr;15(4):538-45
pubmed: 15954234
Endocr Pract. 2019 Dec;25(12):1346-1359
pubmed: 31682518
Obes Facts. 2009;2 Suppl 1:63-6
pubmed: 20124782
Obes Surg. 2015 Oct;25(10):1875-81
pubmed: 25702141
Obes Surg. 2016 Apr;26(4):810-5
pubmed: 26208411

Auteurs

Cui Yang (C)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. cui.yang@umm.de.

Mia Kessler (M)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Niki Taebi (N)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Michael Hetjens (M)

Department of Biomedical Informatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Christoph Reissfelder (C)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Mirko Otto (M)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Georgi Vassilev (G)

Department of Surgery, Medical Faculty Mannheim, University Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH